CacheBy
Thermo Fisher Scientific Human CX3CL1 Synthetic Peptide
원본

Thermo Fisher Scientific Human CX3CL1 Synthetic Peptide

상품 한눈에 보기

인간 CX3CL1의 N말단 18 아미노산 서열에 해당하는 합성 펩타이드. 항체 PA5-20296의 블로킹 펩타이드로 사용 가능. PBS(pH 7.2)와 0.1% BSA로 구성된 용액 형태. -20°C에서 보관. 연구용으로만 사용.

카탈로그번호
PEP0398
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 05. 오후 10:38
Thermo Fisher Scientific PEP0398 Human CX3CL1 Synthetic Peptide 50 ug pk판매 단위 pk ·
재고 확인 필요
195,500원VAT 포함 215,050원

Thermo Fisher Scientific · Thermo Fisher Scientific Human CX3CL1 Synthetic Peptide

Applications

Control (Ctrl)

  • Assay-dependent

Blocking Assay (BLOCK)

  • Assay-dependent

Product Specifications

항목 내용
Species Reactivity Human
Class Synthetic
Type Peptide
Conjugate Unconjugated
Form Liquid
Concentration 200 µg/mL
Purification Purified
Storage buffer PBS, pH 7.2, with 0.1% BSA
Contains 0.02% sodium azide
Storage conditions -20°C

Product Specific Information

This peptide corresponds to 18 amino acids near the amino terminus of human CX3CL1.
PEP-0398 can be used as a blocking peptide with polyclonal antibody PA5-20296.

Target Information

Chemokines are a family of proteins associated with the trafficking of leukocytes in immune surveillance and inflammatory cell recruitment. They are classified based on the positions of key cysteine residues.
CX3CL1 is a CX3C chemokine known to induce adhesion and migration of leukocytes mediated by a membrane-bound and soluble form respectively.
Recent experiments have shown that CX3CL1 can suppress the production of nitrous oxide, interleukin-6, and TNF-a in activated microglia and neuronal cells, suggesting that it may act as an intrinsic inhibitor against neurotoxicity by activated microglia.
Its receptor, CX3CR1, also functions as a co-receptor for HIV-1 and HIV-2 envelope fusion and virus infection, which can be inhibited by CX3CL1.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.